Explore 3 Stock Ideas & Industry Insights Download Free Report

SINTX Technologies Inc

Company price
1.56 USD -0.06 ( 3.70%)
Last update at 2026-11-06T18:35:00Z
VOLUME
16909
Market Cap
11.33M

Momentum Score

…

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.55
Low
1.64
High
52 Week Price Range
1.40
Low
5.14
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
1.62
Dividend Yield
-
Revenue TTM
1.33M
Revenue Per Share
0.34
Gross Profit TTM
0.70M
Debt / Equity
1.11
ROE
-255.86%
Net Debt
-0.89M
ROCE
-178.62%
Diluted EPS TTM
-5.48

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -10.36M -11.02M -8.26M -12.04M -8.78M
Net income -17.08M -11.02M -8.26M -16.49M -9.82M
Selling general administrative 6.20M 4.00M 4.22M 3.99M 3.60M
Selling and marketing expenses 0.24M 0.61M 1.14M 1.34M 1.29M
Gross profit -0.20M 0.43M 1.84M 0.34M 0.16M
Reconciled depreciation 0.66M 1.38M 1.49M 0.96M 0.65M
Ebit -10.31M -10.99M -8.26M -11.34M -10.62M
Ebitda -9.65M -9.61M -6.60M -9.97M -8.82M
Depreciation and amortization 0.66M 1.38M 1.66M 1.37M 1.80M
Operating income -10.72M -14.05M -13.36M -11.34M -10.62M
Other operating expenses 11.74M 15.29M 15.98M 11.94M 11.23M
Interest expense 0.05M 0.03M 0.00M 0.02M 1.84M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.17M 0.11M 0.13M 0.02M 0.10M
Net interest income 0.12M 0.08M 0.12M 0.01M 0.10M
Income tax expense 6.72M - 0.03M 4.45M 1.05M
Total revenue 1.02M 1.25M 2.63M 0.60M 0.61M
Total operating expenses 10.52M 14.48M 15.20M 11.67M 10.78M
Cost of revenue 1.22M 0.81M 0.78M 0.27M 0.45M
Total other income expense net 0.36M 3.02M 5.10M -0.70M 1.84M
Net income from continuing ops -10.36M -11.02M -9.90M -12.04M -8.78M
Net income applicable to common shares - - - -16.49M -8.78M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 9.51M 9.41M 15.37M 15.77M 21.84M
Intangible assets 0.14M 0.02M 0.02M 0.03M 0.03M
Other current assets 0.51M 0.47M 0.62M 0.01M 0.35M
Total liab 6.58M 5.52M 6.59M 10.07M 4.11M
Total stockholder equity 2.93M 3.89M 8.77M 5.70M 17.73M
Other current liab 2.95M 1.20M 1.71M 6.75M 0.35M
Common stock 0.04M 0.01M 0.05M 0.01M 0.25M
Capital stock 0.04M 0.01M 0.05M 0.01M 0.25M
Retained earnings -292.10M -281.74M -270.71M -262.45M -249.88M
Other liab - - - 0.00M -
Good will 0.30M 0.00M - - -
Other assets - - - 0.54M 0.37M
Cash 4.14M 3.60M 3.34M 6.25M 14.27M
Total current liabilities 3.73M 1.98M 2.91M 8.08M 2.21M
Current deferred revenue - - - - 1.15M
Net debt -0.89M 0.43M 0.91M -3.36M -11.88M
Short term debt 0.41M 0.49M 0.56M 0.90M 0.50M
Short long term debt 0.01M 0.03M 0.05M 0.16M -
Short long term debt total 3.25M 4.03M 4.25M 2.89M 2.40M
Other stockholder equity 294.99M 285.62M 279.43M 268.15M 267.36M
Property plant equipment - - - 8.00M 6.41M
Total current assets 5.65M 4.77M 5.53M 7.21M 15.03M
Net tangible assets - - - 5.68M 17.70M
Net receivables 0.18M 0.20M 0.69M 0.33M 0.10M
Long term debt - - - 0.37M -
Inventory 0.82M 0.50M 0.89M 0.28M 0.30M
Accounts payable 0.38M 0.30M 0.64M 0.43M 0.22M
Non currrent assets other 0.48M 0.55M 0.89M 0.54M 0.37M
Non current assets total 3.86M 4.64M 9.83M 8.56M 6.81M
Capital lease obligations 3.24M 3.99M 4.20M 2.36M 2.40M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.19M -0.73M -1.10M -1.65M
Change to liabilities - - - 0.23M 0.26M
Total cashflows from investing activities 0.91M -0.19M -0.50M -1.10M -1.65M
Net borrowings -0.21M -0.35M -0.11M -0.51M 0.51M
Total cash from financing activities 8.20M 9.09M 11.71M 3.34M 0.70M
Change to operating activities - - - -0.70M -0.58M
Net income -10.36M -11.02M -8.26M -12.04M -8.78M
Change in cash 0.54M 0.26M -2.90M -8.03M -11.08M
Begin period cash flow 3.60M 3.34M 6.25M 14.27M 25.35M
End period cash flow 4.14M 3.60M 3.34M 6.25M 14.27M
Total cash from operating activities -8.57M -8.64M -14.12M -10.26M -10.13M
Issuance of capital stock 0.33M 0.00M 0.00M 3.85M 0.00M
Depreciation 0.66M 1.38M 1.66M 0.96M 0.65M
Other cashflows from investing activities 1.10M 0.50M 0.03M - 1.94M
Dividends paid - - 6.53M - -
Change to inventory -0.09M 0.07M -0.48M -0.14M -0.11M
Change to account receivables -0.07M 0.49M -0.42M -0.03M -0.06M
Sale purchase of stock -0.13M 0.00M -0.00M - -
Other cashflows from financing activities 8.20M 3.37M 6.65M 0.00M 0.70M
Change to netincome - - - 1.45M -1.52M
Capital expenditures 0.19M 0.69M 0.53M 1.41M 3.74M
Change in working capital -0.36M 0.29M -1.55M -0.06M -0.08M
Stock based compensation 2.00M 0.08M 0.29M 0.37M 0.31M
Other non cash items -0.51M 0.63M -6.25M 0.50M -1.39M
Free cash flow -8.76M -9.33M -14.64M -11.67M -13.87M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SINT
SINTX Technologies Inc
-0.06
3.70%
1.56 - - 8.52 2.47 10.59 -0.56
ABT
Abbott Laboratories
-2.71
2.39%
110.89 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-2.29
2.18%
102.55 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-9.53
2.84%
325.55 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-2.15
4.12%
49.85 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

SINTX Technologies Inc

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

1885 West 2100 South, Salt Lake City, UT, United States, 84119

801 839 3500

32

Name Title Year Born
Dr. B. Sonny Bal J.D., M.B.A., M.D., MBA, Ph.D. Chairman, Pres, CEO & Principal Financial Officer 1962
Mr. David Francis O'Brien Chief Operating Officer 1965
Ms. Gina Moss Director of Operations NA
Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D. CEO, President, Principal Financial Officer & Chairman 1962
Mr. David Francis O'Brien Executive VP & COO 1965
Mr. Michael Marcroft Vice President of Sales & Marketing NA
Mr. Eric K. Olson CEO & Chairman of the Board 1963
Mr. Kevin Trask Chief Financial Officer 1986
Mr. Gregg Richard Honigblum Chief Investment Officer & Director 1963
Mr. Ryan Elmore President 1975

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…